Press Release: IndSwift : Ind-Swift Laboratories Limited (INDSWFTLAB) - Financial and Strategic SWOT Analysis Review

(PR-inside.com) Ind-Swift Laboratories Limited. (ISLL) is a contract research and manufacturing services (CRAMS) company. It undertakes the manufacturing of active pharmaceutical ingredients (API), allied menthol and mint derivatives and custom chemical products. The company's product portfolio includes API's such as Roxithromycin, Azithromycin, Bexarotene, Deferasirox, and others; allied menthol and mint derivatives such as Mentho Oil Rectified, Mint Terpenes, and Dihydro Myrcenol, among others; and custom chemical products including 5-Hexynoic acid, 2-Flouro-5-bromobenzonitrile, 5-Hexyne-1-ol, and others. Its products find application in the therapeutic area of cardiovascular, antidiabetic, bone resorption inhibitor, Parkinsons disease, and analgesic, among others. ISLL offers services such as drug development, ..